Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Identify rewards credit cards that are easier to qualify for, making your application process smoother. Find your perfect match today!
21,765 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A five-year AI infrastructure deal worth up to $27 billion between Nebius and Meta sparked a broad rally in lumentum,...
Rising costs and higher rates are pressuring traditional bonds. More retirees replacing bond allocations with dividen...
A gripping court filing alleges a spouse exploited surveillance and a seed phrase to drain a vast Bitcoin stash. This...
Interactive Brokers surged in the first half of 2026 as traders flocked to global markets. This guide breaks down the...
Strategy disclosed a large BTC buy funded by STRC, boosting its holdings and shifting crypto funding toward yield-dri...
The average social security check is forecast to rise in 2027 as inflation-linked COLA projections point to a sizable...
Investors are weighing CoreWeave against top AI stocks. This guide explains the risks, introduces three solid alterna...
GhostSwap launches a no-onboarding swap experience that lets users exchange 1,600+ tokens in minutes, without email, ...
NVIDIA forecasts $1 trillion in AI hardware orders through 2027, highlighting the scale of the AI buildout and its im...
Bitcoin teeters near a critical support zone after a pullback from last week’s highs. This bitcoin price analysis: co...
EVgo’s growth hinges on expanding its fast-charging network and capitalizing on policy support. This article outlines...